Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals.

AIDS. 1996 Aug;10(9):935-40. Unique Identifier : AIDSLINE MED/97006432
Boulter AW; Soltanpoor N; Swan AV; Birnbaum W; Johnson NW; Teo CG; Royal College of Surgeons, Department of Dental Sciences, King's; College School of Medicine and Dentistry, London, UK.

Abstract: OBJECTIVE: To examine risk factors associated with Epstein-Barr virus (EBV) replication in the oral epithelium of an HIV-infected cohort. DESIGN: Longitudinal study of behavioural, medication and immunological parameters of HIV-1-seropositive outpatients attending a genitourinary clinic. Outcome measure was EBV DNA positivity in curetted oral squames, as detected by in situ hybridization. Logistic regression for repeated observations of the same individuals was used to analyse how risk changed over time. RESULTS: Fifty six individuals were studied; 158 patient-visits were made in total (mean, 2.8). Of 137 samples curetted from the tongue, 36 were positive for EBV DNA. Recreational drug use, oral sexual practices, therapy with zidovudine and aciclovir, and changes in CD4 and total lymphocyte counts were not associated with changes in risk. Alcohol drinking, elevated CD8 lymphocyte counts and fluconazole therapy were associated with a decreased risk, and cigarette smoking with increased risk. CONCLUSION: Behavioural and HIV-specific immunological changes may play important roles in promoting and affecting the course of oral EBV replication. Rigorous anticandidal therapy and avoidance of cigarette smoking may retard the development of oral hairy leukoplakia.

Keywords: Adult AIDS-Related Opportunistic Infections/ETIOLOGY/*VIROLOGY Female Herpesvirus 4, Human/*ISOLATION & PURIF/PHYSIOLOGY Human HIV Infections/*COMPLICATIONS *HIV-1 Leukoplakia, Hairy/ETIOLOGY Male Middle Age Mouth Mucosa/*VIROLOGY Multivariate Analysis Risk Factors Support, Non-U.S. Gov't Virus Replication CLINICAL TRIAL JOURNAL ARTICLE RANDOMIZED CONTROLLED TRIAL
970330
M9731507

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .